Analyst consensus rating
Vaxcyte Analyst Rating: Strong Buy
Direct answer
Vaxcyte's consensus rating is Strong Buy.
10 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $117.30.
Forecast evidence checked October 15, 2026.
Get free Vaxcyte email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $67.55
- Average price target
- $117.30
- High price target
- $163.00
- Low price target
- $75.00
- Low target gap
- +11%
- Target upside
- +73.6%
- High target gap
- +141.3%
- Target range width
- 130.3%
- Consensus rating
- Strong Buy
- Analysts
- 10
- Evidence date
- October 15, 2026
- Valid through
- October 22, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Vaxcyte?
Vaxcyte has a verified Strong Buy consensus. The same dataset has an average price target of $117.30.
How far are Vaxcyte's low and high targets from the recorded price?
The low target implies +11%, while the high target implies +141.3%.
How many analysts are included in Vaxcyte's consensus?
The verified consensus includes 10 analysts.
How is Vaxcyte's target upside or downside calculated?
The average target of $117.30 is divided by the recorded price of $67.55, then one is subtracted to produce +73.6%. This does not guarantee a future return.
When was Vaxcyte's analyst forecast verified?
The data was verified on 2026-10-15. The dataset is valid through 2026-10-22.